2607.HK · SH PHARMA
Hong Kong · RS rating 61 · As of 2026-10-14
| Price | 11.19 HKD |
|---|---|
| 1-day change | +0.8% |
| RS rating (overall / 1M / 3M / 12M) | 61 / 66 / 43 / 62 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 29 / 28 / 23 |
| Industry group (rank) | Pharma & Biotech (30) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | -4.1% |
| Distance from 52-week high | +10.1% |
| Market cap (USD) | $5.2B |